Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction ; volume:24 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-12 ; date:12.2018
Molecular medicine ; 24, Heft 1 (15.3.2018), 1-12, 12.2018
- Creator
-
Fillmore, Natasha
- Contributor
-
Levasseur, Jody L.
Fukushima, Arata
Wagg, Cory S.
Wang, Wei
Dyck, Jason R. B.
Lopaschuk, Gary D.
SpringerLink (Online service)
- DOI
-
10.1186/s10020-018-0005-x
- URN
-
urn:nbn:de:1111-20180528847
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fillmore, Natasha
- Levasseur, Jody L.
- Fukushima, Arata
- Wagg, Cory S.
- Wang, Wei
- Dyck, Jason R. B.
- Lopaschuk, Gary D.
- SpringerLink (Online service)
Other Objects (12)
Ventricular-arterial uncoupling in heart failure with preserved ejection fraction after myocardial infarction in dogs - invasive versus echocardiographic evaluation
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Ventricular-arterial uncoupling in heart failure with preserved ejection fraction after myocardial infarction in dogs - invasive versus echocardiographic evaluation
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Ventricular-arterial uncoupling in heart failure with preserved ejection fraction after myocardial infarction in dogs - invasive versus echocardiographic evaluation
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction